A nanostructured lipid carrier encapsulates bromelain extract
MYPI2018300001A0Undetermined Publication Date: 2019-07-22UNIVERSITI TEKNOLOGI MALAYSIA
0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2018300001
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2018-01-22
- Publication Date
- 2019-07-22
Abstract
The invention is purposely for Bromelain extract administration in dermal skin layer. Human skin consists of epidermis, dermis and hypodermis. Epidermis or also known stratum corneum is located at the outermost layer of the skin. This stratum corneum acts as a barrier; hence most topical products cannot penetrate it. The impermeability of stratum corneum is due to the intercellular space filled with a lipid-rich matrix arranged in a laminar fashion which consequently leads to robust and waterproofing barrier. Therefore, suitable carrier is important to preserve physicochemical characteristics of Bromelain extract and the carrier must be small enough (nanosize) to penetrate through skin. In drug delivery, the usage of nanoparticles is where the drug is dissolved, entrapped, encapsulated or attached to a nanoparticle matrix. Nanoparticles are microscopic particles whose size is measured in nanometer in range of l0 to 1000 nm. The present invention relates to a nanostructured lipid carrier comprising Bromelain extract encapsulated in lipid matrix, said lipid matrix consisting of triglyceride, glyceryl monostearate, surfactant and water.
Need to check novelty before this filing date? Find Prior Art
